...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Safety evaluation of an alpha-amylase enzyme preparation derived from the archaeal order Thermococcales as expressed in Pseudomonas fluorescens biovar I.
【24h】

Safety evaluation of an alpha-amylase enzyme preparation derived from the archaeal order Thermococcales as expressed in Pseudomonas fluorescens biovar I.

机译:荧光假单胞菌biovar I中表达的古细菌嗜热球菌α-淀粉酶制剂的安全性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BD5088 alpha-amylase derived from archaeal sources has characteristics of pH and temperature tolerance that are well suited to hydrolysis of starch in food processing applications. The production microorganism recipient strain, Pseudomonas fluorescens biovar I, strain MB101, was avirulent after oral administration to mice and does not represent an infectious threat to humans. Repeated dose gavage studies with BD5088 enzyme preparation, up to 13 weeks in duration, showed no systemic toxicity due to the oral route with an NOAEL of 890mg/kg/day as Total Organic Solids. Some irritation occurred in the respiratory tract, which was considered to be a consequence of reflux and aspiration of test material that contained lipopolysaccharide from the Pseudomonas production strain. A 2-week dietary study (0 and 310mg/kg/day) confirmed that there were no respiratory tract effects related to oral ingestion. There was no genotoxic activity based on Ames, mouse lymphoma, mouse micronucleus, and rat lymphocyte chromosomal aberration tests. There was no evidence of allergenic potential based on a comparison of the primary sequence of BD5088 with sequences in an allergen database. The enzyme was labile to pepsin digestion. Based on these data, BD5088 alpha-amylase preparation may be considered safe for use in food production such as corn wet milling.
机译:源自古细菌来源的BD5088α-淀粉酶具有pH和温度耐受性的特性,非常适合食品加工应用中淀粉的水解。生产的微生物受体菌株,荧光假单胞菌biovar I,菌株MB101,在给小鼠口服后无毒,对人类没有传染性。使用BD5088酶制剂进行的重复剂量管饲研究,持续时间长达13周,未发现因口服途径而产生的全身毒性,NOAEL为890mg / kg /天。呼吸道出现了一些刺激,这被认为是含有假单胞菌生产菌株脂多糖的测试物质回流和抽吸的结果。一项为期2周的饮食研究(0和310mg / kg /天)证实,口服摄入对呼吸道没有影响。没有基于Ames,小鼠淋巴瘤,小鼠微核和大鼠淋巴细胞染色体畸变测试的遗传毒性活性。根据BD5088的一级序列与过敏原数据库中序列的比较,没有证据表明存在潜在的过敏原。该酶对胃蛋白酶消化不稳定。基于这些数据,BD5088α-淀粉酶制剂可被认为可安全用于食品生产,例如玉米湿磨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号